Methyldopa: an often overlooked cause of fever and transient hepatocellular dysfunction.
The clinical features and laboratory findings of 78 cases of methyldopa fever are reported. This drug reaction masqueraded as a variety of acute infectious diseases including septicaemia, meningitis, hepatitis and gastroenteritis, occurred within five weeks of starting the drug and appeared to be unrelated to its dosage. Eosinophilia and skin rashes were conspicuous by their absence. In the majority of patients, symptoms were relieved within 48 hours of the withdrawal of the drug. Sixty-one per cent of patients had biochemical evidence of liver damage but jaundice was uncommon. This pattern of mild hepatotoxicity in patients with early febrile reactions to methyldopa contrasts with the later more serious viral hepatitis-like illness due to the drug.
Stanley
P
P
Mijch
A
A
D000328:Adult; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis; D008111:Liver Function Tests; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged
D008750:Methyldopa